Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace

On 6 October, Flexion Therapeutics announced the approval of Zilretta (triamcinolone acetonide [TA] extended-release injectable suspension) for the treatment of pain associated...

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace
GlobalData Healthcare

Big pharma fails to challenge UK price controls as court backs NICE

Big pharma fails to challenge UK price controls as court backs NICE
GlobalData Healthcare

FDA has given Mylan’s Copaxone generic the green light

FDA has given Mylan’s Copaxone generic the green light
Lopamudra Roy

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business
Elly Earls

How voice assistant technology could revolutionise clinical trials

How voice assistant technology could revolutionise clinical trials

Company Releases »

Garments for Controlled Environments

Cleanroom Connection
Garments for Controlled Environments

Fitoclima Walk-In Stability Storage Room Brochure

Aralab
Fitoclima Walk-In Stability Storage Room Brochure

Polyethylene Terephthalate (PET) Packaging Analyser

ABB Analytical Polyethylene Terephthalate (PET) Packaging Analyser

Workforce Solutions Provider for Life Science Organizations

Kelly Services
Workforce Solutions Provider for Life Science Organizations

Quality Management Best Practices: Managing Quality the Toyota Way

NSF Health Sciences, Pharma Biotech Quality Management Best Practices: Managing Quality the Toyota Way

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Belimumab: The frontrunner in Lupus clinical trials

Belimumab: The frontrunner in Lupus clinical trials

Report: Global migraine market forecast to reach $8.7bn by 2026

Report: Global migraine market forecast to reach $8.7bn by 2026